Local delivery in the Denver, Colorado area

A recurring practice, not a one-off journey.
Join a community that shows up together, on a rhythm — at Vivid Minds Wellness..
$225/m
(Founding rate)
4 microdose classes /m (A $600 value)
Unlimited non-psilocybin classes and community events
One-time preparation session before your first class
$400/m
Unlimited microdose classes
Unlimited non-psilocybin classes and community events
2 Guest passes included /m
A complimentary drink at every microdose class
20% off merchandise, monthly members-only events, priority access to retreats and workshops. Ask about membership during any session.
CLASS: Microdose Yoga
LED BY: Mary
TIMES: 9:00 AM &
12:00 PM
• Duration: 1 hour
• Dose: 2 mg microdose
Yoga flow enhanced by an optional 2mg psilocybin microdose. This session is designed for emotional clarity, stress release, and deep relaxation. The microdose is subtle — you stay fully present and in control throughout.
What’s Included:
•Intention setting
• Gentle yoga flow
• Closing circle with herbal tea and snacks
CLASS: Microdose Meditation & Integration
LED BY: Manon
TIMES: 12:00 PM &
6:00 PM
• Duration: 1 hour
• Dose: 2 mg microdose
Guided meditation, enhanced by an optional 2mg psilocybin microdose. This session is designed for emotional clarity, stress release, and deep relaxation. The microdose is subtle — you stay fully present and in control throughout.
What’s Included:
•Intention setting
• Guided meditation
• Closing circle with herbal tea and snacks
CLASS: Open Studio (creative, rotating)
LED BY: Manon
TIME: 9:30 AM
• Duration: 1 hour
• Dose: 2 mg microdose
Something different every week.
CLASS: Gentle Yoga
LED BY: Mary
TIME: 11:15 AM
Gentle yoga flow.
What’s Included:
•Intention setting
• Gentle yoga flow
• Closing circle with herbal tea and snacks
Some centers move you through in minutes.
We do the opposite, on purpose.
Our classes — yoga, meditation and integration, Open Studio — aren't quick transactions.
They're a room you get to know, faces you recognize, and a ritual worth coming back to.
That's what a fast, transactional model can never replicate.
Open Studio is a microdose class like the others — same 2mg dosing, same 60-minute format — just built around a rotating, hands-on creative practice instead of movement or stillness.
Expect clay, pressed botanicals, candle-making, or an occasional guest maker.
A great fit if you want the practice without a yoga mat or meditation cushion.
NO - classes don't roll over, but there's no penalty for using fewer. Many members don't use all four every month.
You're not locked into a specific day. Use your classes on any Monday, Wednesday, or Saturday class that fits your schedule.
Just once. Your first class includes a one-time preparation session; after that, it's a quick consent check-in before each class.
Same dosing, same format length, different practice — Open Studio is creative and hands-on rather than movement- or stillness-based.
Gold Key members receive two monthly guest passes to bring someone along.
Blue Key members can add an extra class for $90. Drop-in rate for non-members is $150.
Psilocybin-assisted therapy is backed by rigorous clinical research from the world’s leading medical institutions. Here are some of the key studies:
A randomized clinical trial at Johns Hopkins School of Medicine found that two doses of psilocybin, combined with supportive psychotherapy, produced large and rapid reductions in depressive symptoms in adults with major depressive disorder. The effects were four times larger than those typically seen with traditional antidepressants.
Source: Davis AK, Barrett FS, et al. “Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder.” JAMA Psychiatry, 2021.
A follow-up study tracked participants from the original Johns Hopkins depression trial for a full year. At 12 months, 75% of participants still showed a clinical response, and 58% were in full remission from depression — from just one or two psilocybin sessions.
Source: Gukasyan N, Davis AK, et al. “Efficacy and Safety of Psilocybin-Assisted Treatment for Major Depressive Disorder: Prospective 12-Month Follow-Up.” Journal of Psychopharmacology, 2022.
In a head-to-head trial published in the New England Journal of Medicine, two doses of psilocybin were compared with a 6-week course of escitalopram (a leading SSRI antidepressant) in patients with moderate-to-severe depression. Remission rates were 57% in the psilocybin group versus 28% in the escitalopram group. Psilocybin also showed faster onset of antidepressant effects and fewer side effects including less drowsiness, sexual dysfunction, and dry mouth.
Source: Carhart-Harris R, Giribaldi B, et al. “Trial of Psilocybin versus Escitalopram for Depression.” New England Journal of Medicine, 2021.
A multi-site, randomized, placebo-controlled Phase 2 trial across 11 U.S. research sites found that a single dose of psilocybin, administered with psychological support, produced rapid and significant antidepressant effects in patients with major depressive disorder compared to placebo.
Source: Raison CL, Sanacora G, et al. “Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.” JAMA, 2023.
Researchers at NYU Grossman School of Medicine found that a single dose of psilocybin, combined with psychotherapy, produced immediate, substantial, and sustained reductions in anxiety and depression in patients with life-threatening cancer diagnoses. Approximately 80% of participants showed clinically significant decreases in distress that endured for more than six months.
Source: Ross S, Bossis A, et al. “Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-Threatening Cancer.” Journal of Psychopharmacology, 2016.
The U.S. Food & Drug Administration has granted psilocybin “Breakthrough Therapy” designation for treatment-resistant depression. This status is reserved for treatments that demonstrate substantial improvement over existing therapies for serious conditions, and it accelerates the development and review process.
Source: COMPASS Pathways received FDA Breakthrough Therapy designation for COMP360 psilocybin therapy in treatment-resistant depression, 2018. Usona Institute received the same designation for major depressive disorder, 2019.
20% off merchandise, monthly members-only events, priority access to retreats and workshops. Ask about membership during any session.


Licensed healing center space in Denver available for certified facilitators. Private sessions, group journeys & classes. Contact Vivid Minds.
This website is for educational and informational purposes only. Psilocybin products are not available for sale through this platform. Any product descriptions and related content are provided for reference purposes only.
By using this website, you acknowledge that psilocybin is a regulated substance in Colorado, and access to legal use is limited under state law. Nothing on this website constitutes an offer to sell, medical advice, or legal advice. Please consult applicable state and local laws before engaging in any activities related to psilocybin.